Benzodiazepine dependence: focus on withdrawal syndrome. 2009

N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
Laboratoire de toxicologie, faculté de pharmacie, 63000 Clermont-Ferrand, France. authier@hotmail.com

Benzodiazepines are potentially addictive drugs: psychological and physical dependence can develop within a few weeks or years of regular or repeated use. The socioeconomic costs of the present high level of long-term benzodiazepine use are considerable. These consequences could be minimised if prescriptions for long-term benzodiazepines were decreased. However, many physicians continue to prescribe benzodiazepines and patients wishing to withdraw receive little advice or support. Particular care should be taken in prescribing benzodiazepines for vulnerable patients such as elderly persons, pregnant women, children, alcohol- or drug-dependent patients and patients with comorbid psychiatric disorders. The following update gives recent research results on the withdrawal pathophysiology and practical information in order to treat or prevent benzodiazepine withdrawal syndrome.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders

Related Publications

N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
January 2002, Psychiatria polska,
N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
October 2004, Drug and alcohol dependence,
N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
January 1983, Maryland state medical journal,
N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
January 1983, Journal of psychoactive drugs,
N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
January 2009, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
January 1998, International journal of psychiatry in clinical practice,
N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
August 1993, Drug safety,
N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
April 1991, La Clinica terapeutica,
N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
March 1991, The British journal of psychiatry : the journal of mental science,
N Authier, and D Balayssac, and M Sautereau, and A Zangarelli, and P Courty, and A A Somogyi, and B Vennat, and P-M Llorca, and A Eschalier
November 1994, Addiction (Abingdon, England),
Copied contents to your clipboard!